載入...
Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
Despite the availability of multiple disease-modifying therapies for relapsing multiple sclerosis (MS), there remains a need for highly efficacious targeted therapy with a favorable benefit–risk profile and attributes that encourage a high level of treatment adherence. Daclizumab is a humanized mono...
Na minha lista:
| 發表在: | Biologics |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5026217/ https://ncbi.nlm.nih.gov/pubmed/27672308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S89218 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|